[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 5, 1935


JAMA. 1935;105(14):1135. doi:10.1001/jama.1935.02760400051020

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  In a communication, in The Journal, June 29, page 2384, Dr. Gilbert Dalldorf concedes to Dr. Irving Sherwood Wright the priority of claim of having first reported on the effect of cevitamic acid on capillary fragility. I think there is a certain amount of danger in specializing claims of that sort. Readers not acquainted with the literature might be led to believe that the idea was altogether new. This is not the case. Alfred F. Hess stated in his monograph on scurvy (Scurvy Past and Present, Philadelphia, J. B. Lippincott Company, 1920, p. 212) that he had obtained normal capillary fragility in scorbutic children when antiscorbutics (now known to contain cevitamic acid) were given. The work of Göthlin (1931) has later added new interest to the subject. Furthermore, the claim is not quite correct. In 1933 I (Treatment of Scurvy in Man with Intravenous Injection of Ascorbic

First Page Preview View Large
First page PDF preview
First page PDF preview